Pharmacokinetics of Digoxin in the Turkey and Comparison with Other Species

Overview

Journal J Pharmacokinet Biopharm

Specialty Pharmacology

Date 1981 Jun 1

PMID 7288595

Authors

E Park

S Einzig

N A STALEY

G R NOREN

Affiliations

Soon will be listed here.

Abstract

Digoxin was administered by bolus intravenous injection to seven broad-breasted white turkey poults at doses of 0.1, 0.15, or 0.2 mg/kg. Plasma digoxin concentrations were measured by a 125I radioimmunoassay at selected times over the subsequent 24 hr. The data were fitted to a two compartment open pharmacokinetic model. Overall mean values for kinetic variables were: distribution halflife, 38.96 min; elimination halflife, 11.03 hr; volume of distribution in the central compartment, 1.54 liters/kg; total body clearance, 5.81 ml/min/kg. Different doses did not appear to have a significant effect on the identifiable pharmacokinetic variables, suggesting that digoxin disposition is dose independent in the turkey. The results obtained in turkeys were compared with data reported for rats, cats, dogs, and humans. The value for total body clearance of digoxin in the turkey was similar to values found in man, dogs, and cats but considerably less than values reported for rats. The value for elimination halflife in turkeys was somewhat less than values reported for infants and dogs; however, it was considerably different than values reported for rats and cats.

References

Ochs H, Greenblatt D, BODEM G, Harmatz J . Dose-independent pharmacokinetics of digoxin in humans. Am Heart J. 1978; 96(4):507-11. DOI: 10.1016/0002-8703(78)90162-x. View

Akera T, Yamamoto S, Chubb J, McNish R, BRODY T . Biochemical basis for the low sensitivity of the rat heart to digitalis. Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(2):81-8. DOI: 10.1007/BF00499048. View

Friedman M, BINE Jr R . Employment of the embryonic duck heart for the detection of minute amounts of a digitalis glycoside (lanatoside C). Proc Soc Exp Biol Med. 2010; 64(2):162-5. DOI: 10.3181/00379727-64-15732. View

Weidler D, Jallad N, Movahhed H, Sakmar E, Wagner J . Pharmacokinetics of digoxin in the cat and comparisons with man and the dog. Res Commun Chem Pathol Pharmacol. 1978; 19(1):57-66. View

Stoll R, Christensen M, Sakmar E, Wagner J . The specificity of the digoxin radioimmunoassay procedure. Res Commun Chem Pathol Pharmacol. 1972; 4(3):503-10. View

Kramer W, Lewis R, Cobb T, Forester Jr W, Visconti J, Wanke L . Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man. J Pharmacokinet Biopharm. 1974; 2(4):299-312. DOI: 10.1007/BF01061404. View

Koup J, Greenblatt D, Jusko W, Smith T, Koch-Weser J . Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. J Pharmacokinet Biopharm. 1975; 3(3):181-92. DOI: 10.1007/BF01067907. View

Harrison L, Gibaldi M . Pharmacokinetics of digoxin in the rat. Drug Metab Dispos. 1976; 4(1):88-93. View

IISALO E . Clinical pharmacokinetics of digoxin. Clin Pharmacokinet. 1977; 2(1):1-16. DOI: 10.2165/00003088-197702010-00001. View

10.

MOORE E . Experimental electrophysiological studies on avian hearts. Ann N Y Acad Sci. 1965; 127(1):127-44. DOI: 10.1111/j.1749-6632.1965.tb49397.x. View

11.

Wagner J . Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses. J Pharmacokinet Biopharm. 1977; 5(2):161-82. DOI: 10.1007/BF01066219. View

12.

Boxenbaum H, RIEGELMAN S, Elashoff R . Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm. 1974; 2(2):123-48. DOI: 10.1007/BF01061504. View

13.

Harrison L, Gibaldi M . Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans. J Pharm Sci. 1977; 66(12):1679-83. DOI: 10.1002/jps.2600661206. View

14.

MARCUS F, Kapadia G, KAPADIA G . THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS. J Pharmacol Exp Ther. 1964; 145:203-9. View

15.

Greenblatt D . Drug therapy. Clinical Pharmacokinetics (first of two parts). N Engl J Med. 1975; 293(14):702-5. DOI: 10.1056/NEJM197510022931406. View

16.

Wettrell G . Distribution and elimination of digoxin in infants. Eur J Clin Pharmacol. 1977; 11(5):329-35. DOI: 10.1007/BF00566529. View

17.

Einzig S, Jankus E, MOLLER J . Round heart disease in turkeys: a hemodynamic study. Am J Vet Res. 1972; 33(3):557-61. View

18.

Gibaldi M, Weintraub H . Some considerations as to the determination and significance of biologic half-life. J Pharm Sci. 1971; 60(4):624-6. DOI: 10.1002/jps.2600600430. View

19.

Doherty J, PERKINS W . Tissue concentration and turnover of tritiated digoxin in dogs. Am J Cardiol. 1966; 17(1):47-52. DOI: 10.1016/0002-9149(66)90259-1. View